Literature DB >> 15793530

Soft tissue infection caused by Gemella morbillorum in two intravenous drug users.

Claude Bachmeyer, Nathalie Landgraf, Laurent Daumas.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15793530     DOI: 10.1016/j.jaad.2004.11.045

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  Gemella morbillorum isolated from a pelvic abscess in an HIV-positive patient with squamous cell carcinoma of the perianal region.

Authors:  Benjamin Edward Ueberroth; Renato Roxas
Journal:  BMJ Case Rep       Date:  2019-05-24

2.  Peroxy Pyruvic Acid-Containing Topical Anti-Infective: A Potential Candidate for a Wound Instillation Solution.

Authors:  Edwin D Neas; Julie A Dunn; Evelyn Dimaano Silva; A Morgan Chambers; Gary J Luckasen; Adam Jaskowiak
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-10-01       Impact factor: 4.730

3.  Gemella morbillorum as a source bacteria for necrotising fasciitis of the torso.

Authors:  Gustavo Romero-Velez; Xavier Pereira; Anil Narula; Peter K Kim
Journal:  BMJ Case Rep       Date:  2020-01-06

4.  Gemella morbillorum as the Culprit Organism of Post-Colonoscopy Necrotizing Perineal Soft Tissue Infection in a Diabetic Patient With Crohn's Disease.

Authors:  Eltaib Saad; Apoorva Tummala; Mohamed Agab; Guillermo Rodriguez-Nava
Journal:  J Med Cases       Date:  2022-03-05

5.  Gemella morbillorum bacteremia following total laparoscopic hysterectomy for uterine corpus cancer.

Authors:  Ai Miyoshi; Takashi Miyatake; Mai Nishimura; Asuka Tanaka; Serika Kanao; Masumi Takeda; Mayuko Mimura; Masaaki Nagamatsu; Takeshi Yokoi
Journal:  Gynecol Minim Invasive Ther       Date:  2016-12-05

6.  A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada.

Authors:  Kristen A Morin; Chad R Prevost; Joseph K Eibl; Michael T Franklyn; Alexander R Moise; David C Marsh
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.